Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8962205 | Radiotherapy and Oncology | 2018 | 5 Pages |
Abstract
Twice daily schedule of re-irradiation of 60â¯Gy/5 weeks with cetuximab was tolerable and no significant difference in treatment delays occurred between two arms.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Yungan Tao, Laura Faivre, Anne Laprie, Pierre Boisselier, Christophe Ferron, Guy Michel Jung, Séverine Racadot, Bernard Gery, Caroline Even, Ingrid Breuskin, Jean Bourhis, François Janot,